Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide and 2,3-dihydro-1,4-phthalazinedione dihydrazone sulfate (1:1) (81569-86-0)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide 1,1-dioxide,5-ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)- pyrimidinetrione monosodium salt and 2-(phenylmethyl)-1H-benzimidazole
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with rel-3-(aminosulfonyl)-4-chloro-N-[(2R,6S)- 2,6-dimethyl-1-piperidinyl]benzamide and (5'R)-12'-hydroxy-2'-(1-methylethyl)-5'- (phenylmethyl)ergotaman-3',6',18-trione monomethanesulfonate (salt)
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)-
- Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl) oxy]-,methyl ester,(3â,16â,17R,18â,20R)-,mixt. with N-[(acetylamino)carbonyl]-2-bromo-2-ethylbutanamide and 3-(2-methylphenoxy)-1,2-propanediol
- Yohimban-16-carboxylic acid,11,17-dimethoxy-12-nitro-18-[(3,4,5- trimethoxybenzoyl)oxy]-,methyl ester,(3â,16â,17R,18â,20R)-
- Yohimban-16-carboxylic acid,18-hydroxy-17-methoxy-,(3â,16â,17R,- 18â,20R)-
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 1(2H)-phthalazinone hydrazone and potassium chloride (kcl)
- methyl (3beta,16beta,17alpha,18beta,20alpha)-17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate - 6-chloro-3-(chloromethyl)-2-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide (1:1)
- Yohimban-16-carboxylic acid,18-ethoxy-11,17-dimethoxy-,methyl ester,(3â,16â,17R,18â,20R)-,(2Z)-2-butenedioate
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide and (17alpha)-17-hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid monopotassium salt
- Yohimban-16-carboxylic acid,17-hydroxy-11-methoxy-,methyl ester,(3â,16â,17R,20R)-
- Yohimban-16-methanol,18-hydroxy-17- methoxy-,(3â,16â,17R,18â,20R)-
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 4-chloro-N(1)-methyl-N(1)-((tetrahydro-2-methyl-2-furanyl)methyl)-1,3-benzenedisulfonamide and 3-hydroxy-alpha-methyl-L-tyrosine
- Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-, mixt. with 4-chloro-N(1)-methyl-N(1)-((tetrahydro-2-methyl-2-furanyl)methyl)-1,3-benzenedisulfonamide and myo-inositol hexa-3-pyridinecarboxylate
- Yohimban-16-carboxylic acid, 1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3β,16β,17α,18β,20α)-, compd. with 5-oxo-l-proline (1:2)
- Cyclopenta[13,17]-18-norandrosta-6,8(14)- dien-11-one,3',4',5',17-tetrahydro-3,5,9- trihydroxy-4'-[(1S,2R)-1-hydroxy-2,3- dimethylbutyl]-3'-methyl-,(3â,3'â,4'â,5â,9â,- 17R)-
- Yohimban-16-carboxylic acid,17-hydroxy-,methyl ester,(3â,16R,17R,20R)-
- Yohimban-16-carboxylic acid,17-hydroxy-9-methoxy-,(3â,16â,17â,- 20R)-
- Aspidospermidine-3-carboxylic acid,4-(acetyloxy)-6,7-didehydro-3-hydroxy- 16-methoxy-1-methyl-,(2â,3â,4â,5R,12â,- 19R)-
- Estr-4-en-3-one,16-ethyl-17-(1- oxopropoxy)-,(16â,17â)-